Form 8-K - Current report:
SEC Accession No. 0001493152-25-010589
Filing Date
2025-03-17
Accepted
2025-03-17 16:28:48
Documents
16
Period of Report
2025-03-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43484
2 ex99-1.htm EX-99.1 26444
3 ex99-1_001.jpg GRAPHIC 17576
  Complete submission text file 0001493152-25-010589.txt   322715

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE hrow-20250317.xsd EX-101.SCH 3943
5 XBRL DEFINITION FILE hrow-20250317_def.xml EX-101.DEF 26961
6 XBRL LABEL FILE hrow-20250317_lab.xml EX-101.LAB 37182
7 XBRL PRESENTATION FILE hrow-20250317_pre.xml EX-101.PRE 25581
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6655
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 25744896
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)